United Bank Proto Kinetix, Inc. Transaction History

United Bank

  • $806 Million
  • Q2 2024

A detailed history of United Bank transactions in Proto Kinetix, Inc. stock. As of the latest transaction made, United Bank holds 50,600 shares of PKTX stock, worth $506. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,600
Previous 50,600 -0.0%
Holding current value
$506
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$0.14 - $0.27 $1,352 - $2,609
-9,664 Reduced 16.04%
50,600 $8,000
Q3 2019

Nov 13, 2019
SELL
$0.1 - $0.29 $15,882 - $46,058
-158,824 Reduced 72.49%
60,264 $6,000
Q4 2017

Feb 15, 2018
BUY
$0.05 - $0.07 $10,954 - $15,336
219,088
219,088 $13,000

Others Institutions Holding PKTX

# of Institutions
2
Shares Held
70.6K
Call Options Held
0
Put Options Held
0
View Full List

About ProtoKinetix, Inc.

PKTX Quotes by TradingView
  • Ticker PKTX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 314,329,984
  • Market Cap $3.14M
  • Description
  • ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collabo...
More about PKTX
Track This Portfolio

Track United Bank Portfolio

Follow United Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email